The tumor suppressor protein p21 Waf1/Cip1 acts as an inhibitor of cell cycle progression.
It functions in stoichiometric relationships forming heterotrimeric complexes with cyclins and cyclin-dependent kinases.
In association with CDK2 complexes, it serves to inhibit kinase activity and block progression through G1/S (1).
However, p21 may also enhance assembly and activity in complexes of CDK4 or CDK6 and cyclin D (2).
The carboxy-terminal region of p21 is sufficient to bind and inhibit PCNA, a subunit of DNA polymerase, and may coordinate DNA replication with cell cycle progression (3).
Upon UV damage or during cell cycle stages when cdc2/cyclin B or CDK2/cyclin A is active, p53 is phosphorylated and upregulates p21 transcription via a p53-responsive element (4).
Protein levels of p21 are downregulated through ubiquitination and proteasomal degradation (5).
Applications:Suitable for use in Western Blot, Immunoprecipitation, Immunohistochemistry.
Other applications not tested.
Recommended Dilution:Western Blot: 1:500-1:2000Immunohistochemistry: 1:50-1:200Immunoprecipitation: 1:20-1:50Optimal dilutions to be determined by the researcher.
Storage and Stability:May be stored at 4°C for short-term only.
Aliquot to avoid repeated freezing and thawing.
Store at -20°C.
Aliquots are stable for 12 months after receipt.
For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
仕様
Size:100ul
Host:rabbit
Source Antibody:human
Grade:Affinity Purified
Purity:Purified by affinity chromatography.
Form:Supplied as a liquid in PBS, pH 7.3, 0.02% sodium azide, 50% glycerol.
Specificity:Recognizes CDKN1A. Species Crossreactivity: human, rat
Isotype:IgG
Calc Applications Abbrev:IHC IP WB
Calc Crossreactivity:Hu Rt
Immunogen:Synthetic peptide corresponding to human CDKN1A.